Cita APA (7a ed.)
Shah, M. A., Shah, A., Luo, L., Paskow, M. J., Dempster, S., & Rahma, O. E. (2026 Supplsmsnr 2). REPERTOIRE: Real-world treatment (tx) patterns and outcomes in US patients (pts) with HER2-negative (HER2-) advanced gastric, gastroesophageal junction and esophageal adenocarcinoma (GC/GEJC/EAC). Journal of Clinical Oncology, 44, 306-493.
Cita Chicago Style (17a ed.)
Shah, Manish A., Anuj Shah, Linlin Luo, Michael Jonathan Paskow, Sara Dempster, y Osama E. Rahma. "REPERTOIRE: Real-world Treatment (tx) Patterns and Outcomes in US Patients (pts) with HER2-negative (HER2-) Advanced Gastric, Gastroesophageal Junction and Esophageal Adenocarcinoma (GC/GEJC/EAC)." Journal of Clinical Oncology 44 (2026 Supplsmsnr 2): 306-493.
Cita MLA (9a ed.)
Shah, Manish A., et al. "REPERTOIRE: Real-world Treatment (tx) Patterns and Outcomes in US Patients (pts) with HER2-negative (HER2-) Advanced Gastric, Gastroesophageal Junction and Esophageal Adenocarcinoma (GC/GEJC/EAC)." Journal of Clinical Oncology, vol. 44, 2026 Supplsmsnr 2, pp. 306-493.
Precaución: Estas citas no son 100% exactas.